Do minor differences in primary therapy influence rescue-ability after relapse in childhood ALL?
Zwaan
C M
CM
Veerman
A J P
AJ
D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007262:Infusions, Intravenous; D015122:Mercaptopurine / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence; D016879:Salvage Therapy; D015996:Survival Rate
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine